Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT00469820
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Confirmed diagnosis of 1 of the following:
* Acute myeloid leukemia (AML), meeting any of the following criteria:
* Relapsed disease
* AML arising from myelodysplastic syndromes
* Primary refractory disease
* De novo AML with high-risk features
* Acute lymphoblastic leukemia (ALL), meeting any of the following criteria:
* De novo ALL that is Philadelphia chromosome positive or with t(4,11) cytogenetic features
* Relapsed disease
* Multiple myeloma (in need of treatment)
* Planning to undergo HLA-matched related sibling nonmyeloablative hematopoietic stem cell transplantation
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00469820
Study Brief:
Protocol Section:
NCT00469820